At NS Pharma, clinical trials follow extensive research and development of candidate compounds. We conduct qualitative assessments with analytical research and then develop pharmaceutical formulations. And we continue to challenge ourselves to find new and better solutions during product development.
Patient safety is our top priority and our goal is to manufacture life-changing therapies that are both safe and effective in treating rare diseases like Duchenne muscular dystrophy, eosinophilic granulomatosis with polyangiitis (EGPA) and others. Use the links below to access more information about our clinical trials.
